{
    "N/R/U": null,
    "Applicant": "Mylan Pharmaceuticals Inc.",
    "BLA Number": "210605",
    "Proprietary Name": "Semglee",
    "Proper Name": "insulin glargine",
    "BLA Type": "351(a)",
    "Strength": "1,000UNITS/10ML (100 UNITS/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Multi-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "11-Jun-20",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2210",
    "Product Number": "1",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}